• NICE backs use of Roche's Gazyvaro with bendustamine pharmatimes
    May 14, 2020
    Patients with follicular lymphoma will now get NHS-funded treatment with Roche's Gazyvaro (binutuzumab)/bendamustine in England and Wales after cost regulators published guidelines backing its use in this setting.
  • Venclyxto gains approval in Europe pharmatimes
    March 16, 2020
  • Four new medicines available via NHS Scotland pharmatimes
    November 27, 2018
  • Roche hails 4 year NICE access deal for Gazyvaro pharmaphorum
    July 27, 2017
    NICE has agreed a deal with Roche on its new follicular lymphoma treatment Gazyvaro, giving the drug up to four years to prove its value to patients.
PharmaSources Customer Service